Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA
  • 2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...
  • 2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...
  • 2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars
  • 2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...
  • 2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...
  • 2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...
  • 2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...
  • 2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial
  • 2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...
  • 2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...
  • 2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...
  • 2/21/2025MediLink's YL217 Received FDA Clearance of IND Application
  • 2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...
  • 2/18/2025NovoCodex's ARX788 Demonstrates Efficacy in HER2-Positive Advanced Bre...
  • 2/18/2025BioKin Initiates Phase III Trial in China for BL-B01D1 in NSCLC
  • 2/18/2025Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...
  • 2/17/2025Betta Pharma's Xcovery Initiates EMA Approval Process for Ensartinib i...
  • 2/17/2025BioNTech Initiates Phase 1/2 Trial for BNT327 and BNT323 Combination i...
  • 2/17/2025CSPC's SYS6005 ADC Enters Phase I Clinical Trials in China
  • 2/14/2025China Approves Novo Nordisk's Semaglutide Injection for New Indication
  • 2/14/2025NMPA Approves Sinocelltech's Finotonlimab for R/M HNSCC
  • 2/14/2025Trinomab's TNM002: A New Passive Immunization Agent for Emergency Teta...
  • 2/14/2025NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
  • 2/13/2025Jiangsu Recbio's Novel HPV Vaccine Trial Approved in China
  • 2/12/2025Lion TCR's Liocyx-M004 Receives FDA IND Approval for Phase 2 Trial
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/12/2025Merck Registers Kelun's Nectin-4 ADC MK-3120 and Initiates Phase 1 Tri...
  • 2/11/2025IVIEW Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic Eyeli...
  • 2/11/2025BioKin Pharma's HER2 ADC BL-M07D1 Advances to Phase III in China
  • Page:8/15 Total number of articles:433: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group